These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15033164)

  • 41. Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: implications for reinforcement and reinstatement.
    Zhai H; Li Y; Wang X; Lu L
    Cell Mol Neurobiol; 2008 Feb; 28(2):157-72. PubMed ID: 18041576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptomic and proteomic analyses of mouse cerebellum reveals alterations in RasGRF1 expression following in vivo chronic treatment with delta 9-tetrahydrocannabinol.
    Colombo G; Rusconi F; Rubino T; Cattaneo A; Martegani E; Parolaro D; Bachi A; Zippel R
    J Mol Neurosci; 2009 Feb; 37(2):111-22. PubMed ID: 18584336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central excitatory effects of delta 1- and delta 6-tetrahydrocannabinol.
    Segal M; Asscher Y
    Isr J Med Sci; 1973; 9 Suppl():31-42. PubMed ID: 10189870
    [No Abstract]   [Full Text] [Related]  

  • 44. Transcriptomic Profiling after In Vitro Δ
    Chiricosta L; D'Angiolini S; Gugliandolo A; Salamone S; Pollastro F; Mazzon E
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade.
    Rubino T; Viganò D; Premoli F; Castiglioni C; Bianchessi S; Zippel R; Parolaro D
    Mol Neurobiol; 2006 Jun; 33(3):199-213. PubMed ID: 16954596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Cannabis on Glutamatergic Neurotransmission: The Interplay between Cannabinoids and Glutamate.
    Chowdhury KU; Holden ME; Wiley MT; Suppiramaniam V; Reed MN
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994982
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabinoids, Endocannabinoids and Sleep.
    Kesner AJ; Lovinger DM
    Front Mol Neurosci; 2020; 13():125. PubMed ID: 32774241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Cerebellum, THC, and Cannabis Addiction: Findings from Animal and Human Studies.
    Moreno-Rius J
    Cerebellum; 2019 Jun; 18(3):593-604. PubMed ID: 30610540
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurobiology of Propofol Addiction and Supportive Evidence: What Is the New Development?
    Xiong M; Shiwalkar N; Reddy K; Shin P; Bekker A
    Brain Sci; 2018 Feb; 8(2):. PubMed ID: 29470436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Δ
    Lazenka MF; Kang M; De DD; Selley DE; Sim-Selley LJ
    Cannabis Cannabinoid Res; 2017; 2(1):224-234. PubMed ID: 29082320
    [No Abstract]   [Full Text] [Related]  

  • 51. Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects.
    Sun WL; Quizon PM; Zhu J
    Prog Mol Biol Transl Sci; 2016; 137():1-40. PubMed ID: 26809997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption.
    Llorente-Berzal A; Puighermanal E; Burokas A; Ozaita A; Maldonado R; Marco EM; Viveros MP
    PLoS One; 2013; 8(11):e78386. PubMed ID: 24223797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.
    Panlilio LV; Justinova Z; Goldberg SR
    Pharmacol Ther; 2013 Apr; 138(1):84-102. PubMed ID: 23333350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prior exposure to THC increases the addictive effects of nicotine in rats.
    Panlilio LV; Zanettini C; Barnes C; Solinas M; Goldberg SR
    Neuropsychopharmacology; 2013 Jun; 38(7):1198-208. PubMed ID: 23314220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system.
    Hoffman AF; Lupica CR
    Cold Spring Harb Perspect Med; 2013 Aug; 3(8):. PubMed ID: 23209160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Brain regional differences in CB1 receptor adaptation and regulation of transcription.
    Lazenka MF; Selley DE; Sim-Selley LJ
    Life Sci; 2013 Mar; 92(8-9):446-52. PubMed ID: 22940268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.
    Fishbein M; Gov S; Assaf F; Gafni M; Keren O; Sarne Y
    Exp Brain Res; 2012 Sep; 221(4):437-48. PubMed ID: 22821081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
    Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
    Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of Neuronal Function by Ras-GRF Exchange Factors.
    Feig LA
    Genes Cancer; 2011 Mar; 2(3):306-19. PubMed ID: 21779501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells.
    Dalton GD; Howlett AC
    Br J Pharmacol; 2012 Apr; 165(8):2497-511. PubMed ID: 21518335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.